$11.99
2.12% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US74766Q1013
Symbol
QTRX
Sector
Industry

Quanterix Corporation Stock price

$11.99
-1.33 9.99% 1M
-16.29 57.60% 6M
-15.35 56.14% YTD
-14.41 54.58% 1Y
-39.60 76.76% 3Y
-12.94 51.91% 5Y
-5.48 31.37% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.26 2.12%
ISIN
US74766Q1013
Symbol
QTRX
Sector
Industry

Key metrics

Market capitalization $460.16m
Enterprise Value $202.88m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.57
P/S ratio (TTM) P/S ratio 3.56
P/B ratio (TTM) P/B ratio 1.37
Revenue growth (TTM) Revenue growth 15.52%
Revenue (TTM) Revenue $129.33m
EBIT (operating result TTM) EBIT $-58.92m
Free Cash Flow (TTM) Free Cash Flow $-40.26m
Cash position $296.86m
EPS (TTM) EPS $-1.04
P/E forward negative
P/S forward 3.38
EV/Sales forward 1.49
Short interest 5.58%
Show more

Is Quanterix Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Quanterix Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Quanterix Corporation forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Quanterix Corporation forecast:

Buy
83%
Hold
17%

Financial data from Quanterix Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
129 129
16% 16%
100%
- Direct Costs 59 59
10% 10%
45%
71 71
21% 21%
55%
- Selling and Administrative Expenses 88 88
16% 16%
68%
- Research and Development Expense 29 29
27% 27%
22%
-47 -47
15% 15%
-36%
- Depreciation and Amortization 12 12
63% 63%
9%
EBIT (Operating Income) EBIT -59 -59
22% 22%
-46%
Net Profit -40 -40
40% 40%
-31%

In millions USD.

Don't miss a Thing! We will send you all news about Quanterix Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quanterix Corporation Stock News

Positive
Seeking Alpha
12 days ago
Today, we revisit Quanterix Corporation, which provides ultra-sensitive digital assay platforms for detecting protein biomarkers in healthcare. The company has a pristine balance sheet with some $300 million in net cash on it.  Quanterix Corporation is also seeing steady revenue growth. Unfortunately, the firm is making little progress on the profitability front but is pushing further into earl...
Neutral
Business Wire
19 days ago
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultra-sensitive biomarker detection, today announced that it appointed Jeffrey Elliott to its Board of Directors. Mr. Elliott brings two decades of senior leadership experience in the medical diagnostics industry, including 8 years at Exact Science...
Neutral
Seeking Alpha
29 days ago
Quanterix Corporation (QTRX) Q2 2024 Earnings Call Transcript
More Quanterix Corporation News

Company Profile

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Head office United States
CEO Masoud Toloue
Employees 441
Founded 2007
Website www.quanterix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today